Sclerotherapy: Background, Etiology, Indications (2024)

Sections

Sclerotherapy

  • Sections Sclerotherapy

  • Overview
    • Background
    • Etiology
    • Indications
    • Relevant Anatomy
    • Contraindications
    • Show All
  • Workup
    • Imaging Studies
    • Other Tests
    • Show All
  • Treatment
    • Surgical Therapy
    • Preoperative Details
    • Intraoperative Details
    • Postoperative Details
    • Complications
    • Future and Controversies
    • Show All
  • Guidelines
  • Media Gallery
  • References

Overview

Background

Sclerotherapy, in which a solution is injected into a vein, causing it to collapse, scar, and fade,remains the primary treatment for small-vessel varicose disease of the lower extremities. [1, 2] These small vessels include telangiectasias, venulectasias, and reticular ectasias. Telangiectasias are flat red vessels smaller than 1 mm in diameter. Venulectasias are blue, sometimes distended above the skin surface, and smaller than 2 mm in diameter. Reticular veins have a cyanotic hue and are 2-4 mm in diameter. Large varicosities do not respond as well as small varicosities to sclerotherapy. [3, 4] See the images below.

Telangiectasias.

View Media Gallery

Venulectasias.

View Media Gallery

Reticular veins.

View Media Gallery

Treatment of telangiectasias, venulectasias, and reticular veins may greatly improve their appearance (see the image below). Treatment may also improve the associated painful symptoms. These vascular abnormalities are common. Telangiectasias are present in up to 28.9% of men and 40.9% of women. [5]

Venulectasias after sclerotherapy treatment.

View Media Gallery

A single-center, prospective study by Cuffolo et al indicated that foam sclerotherapy is effective against venous ulcers. In varicose vein patients with venous ulceration, 3% sodium tetradecyl sulfate was administered to occlude incompetent superficial veins of over 3 mm, with compression treatment subsequently applied. The investigators found at 6-week follow-up that in 21% and 46.1% of patients, respectively, ulcers had either completely healed or undergone clinical improvement (with no additional venous incompetence). Among patients followed up at 1 year, healing had been maintained in 77.1% of ulcers. [6]

Sclerotherapy: Background, Etiology, Indications (1)

Etiology

Genetics and individual behavior patterns are important factors in the development venous disorders. Familial inheritance is reported in 15-40% of cases. Caucasians are most commonly affected. Pregnancy, prolonged standing, and prolonged walking also predispose people to venous disease. [7, 8]

The presence of clusters of reticular veins and telangiectasias on the lateral thigh area is called the lateral subdermic plexus of Albanese and is considered to be a remnant of embryonic development. The presence of clusters of telangiectatic veins on the medial or the lateral aspects of the ankle region is likely the result of incompetence in the great saphenous vein (medial) or the small saphenous vein (lateral). Finding a collection of telangiectatic veins along the medial thigh or knee areas should generate suspicion about an underlying incompetence in the great saphenous vein. Any concern about an underlying saphenous vessel insufficiency should warrant an investigation of the lower extremities by duplex ultrasonography.

Sclerotherapy: Background, Etiology, Indications (2)

Previous

Next:

Indications

The major indications for sclerotherapy are to improve cosmetic appearance and to reduce the associated symptoms such as pain and burning. Sclerotherapy can also be used to treatment any remnant tributaries after endovenous laser ablation of a saphenous or truncal vessel.

Visual sclerotherapy refers to the process of injecting a sclerosant into target veins without the aid of ultrasonography, whereas duplex-guided sclerotherapy (endovenous chemical ablation) is performed using duplex ultrasonography to guide the injections. This article discusses visual sclerotherapy only.

Sclerotherapy: Background, Etiology, Indications (3)

Previous

Next:

Relevant Anatomy

A thorough review the lower extremity venous system is essential before treatment is administered. Venous anatomy is very variable in some parts of the lower extremities but more constant in other parts. The lower extremity has both a superficial and a deep venous system. The deep venous system includes the femoral, popliteal, anterior tibial, posterior tibial, peroneal veins, and others. The superficial system is tremendously complex and extremely variable; it includes the great and short saphenous systems and other unnamed veins. The great and short saphenous veins occasionally connect by intersaphenous veins, such as the Giacomini vein. Several communicating vessels, called perforating veins, are present between the 2 superficial and deep systems. Occasionally, telangiectasias may communicate directly with the deep system.

Sclerotherapy: Background, Etiology, Indications (4)

Previous

Next:

Contraindications

Contraindications to sclerotherapy include pregnancy, thrombophlebitis, pulmonary emboli, hypercoagulable states, and allergy to the sclerosing agents.

Sclerotherapy: Background, Etiology, Indications (5)

Previous

Workup

References
  1. Guo L, Huang R, Zhao D, et al. Long-term efficacy of different procedures for treatment of varicose veins: a network meta-analysis. Medicine (Baltimore). 2019 Feb. 98 (7):e14495. [QxMD MEDLINE Link]. [Full Text].

  2. Rabe E, Breu FX, Flessenkamper I, et al. Sclerotherapy in the treatment ofvaricose veins: S2k guideline of the Deutsche Gesellschaft für Phlebologie (DGP) in cooperation with the following societies: DDG, DGA, DGG, BVP. Hautarzt. 2020 Nov 30. [QxMD MEDLINE Link]. [Full Text].

  3. Kahle B, Leng K. Efficacy of sclerotherapy in varicose veins-- prospective, blinded, placebo-controlled study. Dermatol Surg. 2004 May. 30(5):723-8; discussion 728. [QxMD MEDLINE Link].

  4. Tisi PV, Beverley C, Rees A. Injection sclerotherapy for varicose veins. Cochrane Database of Systematic Reviews. 2006. Issue 4, Art. No.: CD001732. DOI: 10.1002/14651858.CD001732.pub2.:1372.

  5. Engel A, Johnson ML, Haynes SG. Health effects of sunlight exposure in the United States. Results from the first National Health and Nutrition Examination Survey, 1971-1974. Arch Dermatol. 1988 Jan. 124(1):72-9. [QxMD MEDLINE Link].

  6. Cuffolo G, Hardy E, Perkins J, Hands LJ. The effects of foam sclerotherapy on ulcer healing: a single-centre prospective study. Ann R Coll Surg Engl. 2019 Apr. 101 (4):285-9. [QxMD MEDLINE Link].

  7. Parsons ME. Sclerotherapy basics. Dermatol Clin. 2004 Oct. 22(4):501-8, xi. [QxMD MEDLINE Link].

  8. Sadick NS. Predisposing factors of varicose and telangiectatic leg veins. J Dermatol Surg Oncol. 1992 Oct. 18(10):883-6. [QxMD MEDLINE Link].

  9. Raymond-Martimbeau P. The role of duplex ultrasound in the sclerotherapy of varicose veins. Phlebology Digest. 1994. 1:4-10.

  10. Feied CF. Sclerosing Solutions. Fronek H, ed. The Fundamentals of Phlebology, Venous Disease for Clinicians. 2nd. American College of Phlebology; 2007. 23.

  11. Kern P, Ramelet AA, Wutschert R, Bounameaux H, Hayoz D. Single-blind, randomized study comparing chromated glycerin, polidocanol solution, and polidocanol foam for treatment of telangiectatic leg veins. Dermatol Surg. 2004 Mar. 30(3):367-72; discussion 372. [QxMD MEDLINE Link].

  12. Breu FX, Guggenbichler S. European consensus meeting on foam sclerotherapy. Dermatol Surg. 2004. 30:709-717.

  13. Moreno-Moraga J, Pascu ML, Alcolea JM, et al. Effects of 1064-nm Nd:YAG long-pulse laser on polidocanol microfoam injected for varicose vein treatment: a controlled observational study of 404 legs, after 5-year-long treatment. Lasers Med Sci. 2019 Feb 1. [QxMD MEDLINE Link].

  14. Jimenez JC, Lawrence PF, Woo K, et al. Adjunctive techniques to minimize thrombotic complications following microfoam sclerotherapy of saphenous trunks and tributaries. J Vasc Surg Venous Lymphat Disord. 2020 Nov 26. [QxMD MEDLINE Link].

  15. [Guideline] Lurie F, Lal BK, Antignani PL, et al. Compression therapy after invasive treatment of superficial veins of the lower extremities: clinical practice guidelines of the American Venous Forum, Society for Vascular Surgery, American College of Phlebology, Society for Vascular Medicine, and International Union of Phlebology. J Vasc Surg Venous Lymphat Disord. 2019 Jan. 7 (1):17-28. [QxMD MEDLINE Link].

  16. Weiss RA, Sadick NS, Goldman MP, Weiss MA. Post-sclerotherapy compression: controlled comparative study of duration of compression and its effects on clinical outcome. Dermatol Surg. 1999 Feb. 25(2):105-8. [QxMD MEDLINE Link].

  17. Zimmet SE. The prevention of cutaneous necrosis following extravasation of hypertonic saline and sodium tetradecyl sulfate. J Dermatol Surg Oncol. 1993 Jul. 19(7):641-6. [QxMD MEDLINE Link].

  18. Kern P, Ramelet AA, Wutschert R, Hayoz D. Compression after sclerotherapy for telangiectasias and reticular leg veins: a randomized controlled study. J Vasc Surg. 2007 Jun. 45(6):1212-6. [QxMD MEDLINE Link].

  19. Goldman MP. Complications and Adverse Sequelae of Sclerotherapy. Bergan JJ, ed. The Vein Book. Elsevier Academic Press; 2007. 139.

  20. Guex JJ, Allaert FA, Gillet JL, Chleir F. Immediate and midterm complications of sclerotherapy: report of a prospective multicenter registry of 12,173 sclerotherapy sessions. Dermatol Surg. 2005 Feb. 31(2):123-8; discussion 128. [QxMD MEDLINE Link].

  21. Gillet JL, Desnos CH, Lausecker M, Daniel C, Guex JJ, Allaert FA. Sclerotherapy is a safe method of treatment of chronic venous disorders in older patients: A prospective and comparative study of consecutive patients. Phlebology. 2017 May. 32 (4):234-40. [QxMD MEDLINE Link].

  22. [Guideline] Wong M, Parsi K, Myers K, et al. Sclerotherapy of lower limb veins: Indications, contraindications and treatment strategies to prevent complications - A consensus document of the International Union of Phlebology-2023. Phlebology. 2023 May. 38 (4):205-58. [QxMD MEDLINE Link].

  23. [Guideline] National Clinical Guideline Centre (UK). Varicose Veins in the Legs: The Diagnosis and Management of Varicose Veins. 2013 Jul. [QxMD MEDLINE Link]. [Full Text].

Media Gallery

  • Telangiectasias.

  • Reticular veins.

  • Venulectasias.

  • Venulectasias after sclerotherapy treatment.

of 4

Tables

    Sclerotherapy: Background, Etiology, Indications (6)

    Sclerotherapy: Background, Etiology, Indications (7)

    Back to List

    Contributor Information and Disclosures

    Author

    Samer Alaiti, MD, RVT, RPVI, FACP Medical Director, Miracle Mile Medical Center for Dermatology and Cosmetic Surgery, Inc

    Samer Alaiti, MD, RVT, RPVI, FACP is a member of the following medical societies: American Academy of Dermatology, American College of Phlebology, American College of Physicians-American Society of Internal Medicine, American Society for Dermatologic Surgery, American Society for Laser Medicine and Surgery

    Disclosure: Nothing to disclose.

    Specialty Editor Board

    Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

    Disclosure: Received salary from Medscape for employment. for: Medscape.

    Mark E Krugman, MD Assistant Professor of Plastic Surgery, Clinical Professor of Otolaryngology-Head and Neck Surgery, University of California at Irvine School of Medicine

    Mark E Krugman, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Surgeons, American Society of Plastic Surgeons, American Academy of Facial Plastic and Reconstructive Surgery, American Society for Aesthetic Plastic Surgery, American Society for Laser Medicine and Surgery

    Disclosure: Nothing to disclose.

    Chief Editor

    Jorge I de la Torre, MD, FACS Professor of Surgery and Physical Medicine and Rehabilitation, Chief, Division of Plastic Surgery, Residency Program Director, University of Alabama at Birmingham School of Medicine; Director, Center for Advanced Surgical Aesthetics

    Jorge I de la Torre, MD, FACS is a member of the following medical societies: American Burn Association, American College of Surgeons, American Medical Association, American Society for Laser Medicine and Surgery, American Society of Maxillofacial Surgeons, American Society of Plastic Surgeons, American Society for Reconstructive Microsurgery, Association for Academic Surgery, Medical Association of the State of Alabama

    Disclosure: Nothing to disclose.

    Additional Contributors

    Shahin Javaheri, MD Chief, Department of Plastic Surgery, Martinez Veterans Affairs Outpatient Clinic; Consulting Staff, Advanced Aesthetic Plastic & Reconstructive Surgery

    Shahin Javaheri, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American Society of Plastic Surgeons

    Disclosure: Nothing to disclose.

    Acknowledgements

    The authors and editors of Medscape Drugs & Diseases gratefully acknowledge the contributions of previous authors Laurence Z Rosenberg, MD; Jorge I de la Torre, MD, FACS; Gary D Monheit, MD; and John D Kayal, MD; to the development and writing of this article.

    Close

    What would you like to print?

    What would you like to print?

    • Print this section
    • Print the entire contents of
    • Print the entire contents of article
    Sclerotherapy: Background, Etiology, Indications (2024)

    References

    Top Articles
    Latest Posts
    Article information

    Author: Errol Quitzon

    Last Updated:

    Views: 6682

    Rating: 4.9 / 5 (79 voted)

    Reviews: 94% of readers found this page helpful

    Author information

    Name: Errol Quitzon

    Birthday: 1993-04-02

    Address: 70604 Haley Lane, Port Weldonside, TN 99233-0942

    Phone: +9665282866296

    Job: Product Retail Agent

    Hobby: Computer programming, Horseback riding, Hooping, Dance, Ice skating, Backpacking, Rafting

    Introduction: My name is Errol Quitzon, I am a fair, cute, fancy, clean, attractive, sparkling, kind person who loves writing and wants to share my knowledge and understanding with you.